Clinical Trial Update: Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating different drug combinations to treat newly diagnosed multiple myeloma in patients who are not eligible for stem cell tran…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Plasma Cell Myeloma | Phase 3 | Status: RECRUITING